Monoclonal antibodies for the treatment of COVID‐19 in a patient with high‐risk acute leukaemia-Reference-Cited by-同舟云学术

Monoclonal antibodies for the treatment of COVID‐19 in a patient with high‐risk acute leukaemia

Published:2021-08 Issue:1 Volume:196 Page:
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Saultier Paul¹²^ORCID,Ninove Laetitia³,Szepetowski Sarah¹,Veneziano Mathilde¹,Visentin Sandrine¹,Barlogis Vincent¹,Saba Villarroel Paola Mariela³,Amroun Abdennour³,Loosveld Marie⁴^ORCID,de Lamballerie Xavier³,Chambost Hervé¹²^ORCID

Affiliation:

1. Department of Pediatric Hematology, Immunology, and Oncology APHM La Timone Children’s Hospital MarseilleFrance

2. Aix Marseille Univ INSERM INRAe C2VN MarseilleFrance

3. Unité des Virus Émergents UVE: Aix Marseille Univ IRD 190 INSERM 1207 Hôpitaux Universitaires de Marseille MarseilleFrance

4. Laboratory of Hematology APHM La Timone Hospital Marseille France

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.17756

Reference6 articles.

1. Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients

2. Clinical presentations and outcomes of children with cancer and COVID‐19: A systematic review

3. Neutralizing Antibody Therapeutics for COVID-19

4. Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer

5. Acute Immune Signatures and Their Legacies in Severe Acute Respiratory Syndrome Coronavirus-2 Infected Cancer Patients

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges in Treating Pediatric Cancer Patients during the COVID-19 Pandemic: Balancing Risks and Care;Viruses;2024-04-26

2. A bovine antibody possessing an ultralong complementarity-determining region CDRH3 targets a highly conserved epitope in sarbecovirus spike proteins;Journal of Biological Chemistry;2022-12

3. Neutralizing monoclonal antibodies for early treatment of hospital‐acquired SARS‐CoV‐2 infection in hematologic patients;eJHaem;2022-09-02

4. Management of Hematologic Malignancies in the Era of COVID-19 Pandemic: Pathogenetic Mechanisms, Impact of Obesity, Perspectives, and Challenges;Cancers;2022-05-19

5. Comprehensive Treatment of Hematological Patients with SARS-CoV-2 Infection Including Anti-SARS-CoV-2 Monoclonal Antibodies: A Single-Center Experience Case Series;Current Oncology;2022-03-26